Pembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH)
Titel:
Pembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH)
Auteur:
Mauti, L. Rivalland, G. Klingbiel, D. Kao, S. Schmid, S. Nowak, A. Gautschi, O. Hughes, B. Bartnick, T. Pavlakis, N. Bouchaab, H. O'Byrne, K. Rothschild, S. Russell, P. Savic Prince, S. Thapa, B. Pless, M. von Moos, R. Metaxas, Y. John, T.